Tech Company Financing Transactions
U3 Pharma AG Funding Round
U3 Pharma AG secured a $34 million Series C financing round on 5/23/2006. Investors included Alta Partners, Atlas Venture and Edbi.
Transaction Overview
Company Name
Announced On
5/23/2006
Transaction Type
Venture Equity
Amount
$34,000,000
Round
Series C
Investors
Proceeds Purpose
U3 Pharma plans to use the funding for the development of the company's pipeline of antibody-based targeted cancer therapeutics.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Fraunhoferstraße 22
Martinsried, 82152
Germany
Martinsried, 82152
Germany
Phone
Website
Email Address
Overview
U3 Pharma AG is an emerging leader in targeted cancer drug development. The company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder - Prof. Axel Ullrich.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shoji Hirashima
Chief Scientific Officer
Johannes Bange
Browse more venture capital transactions:
Prev: 5/23/2006: INRIX venture capital transaction
Next: 5/23/2006: ArchPro Design Automation venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs